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A B S T R A C T
A mouse iPSC line, IISHDOi005-A, generated from ﬁbroblasts obtained from a mouse C57BL/6J with an age of 1 year and a half, has been obtained. For this purpose,
reprogramming factors Oct3/4, Sox2, Klf4, and c-Myc were delivered using Sendai virus.
Resource table.
Unique stem cell line id-
entiﬁer
IISHDOi005-A
Alternative name(s) of
stem cell line
CmC57-FiPS4F1
Institution Instituto de Investigación Sanitaria Hospital 12 de
Octubre, i+ 12. Madrid, Spain
Contact information of
distributor
Dr. M. Esther Gallardo
egallardo.imas12@h12o.es
Type of cell line iPSC
Origin Mouse
Additional origin info Age: 1.5 years
Sex: Female
Ethnicity if known: N/A
Cell Source Skin ﬁbroblasts
Clonality Clonal
Method of reprogram-
ming
Transgene free (Sendai virus)
Genetic Modiﬁcation NO
Type of Modiﬁcation N/A
Associated disease N/A
Gene/locus N/A
Method of modiﬁcation N/A
Name of transgene or r-
esistance
N/A
Inducible/constitutive s-
ystem
N/A
Date archived/stock date 20 September 2017
Cell line repository/bank N/A
Ethical approval This study was reviewed and approved by the
Institutional Ethical Committee of the “Instituto de
Investigaciones Biomédicas Alberto Sols”, CSIC-UAM, 406
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Resource utility
The main biological hallmarks of aging include stem cell exhaustion
and cellular senescence. Nowadays, there are increasing research eﬀorts
to look for anti-aging therapies. The iPSC line reported here could be a
very useful resource for modelling aging and for designing therapeutic
strategies against it.
Resource details
The mouse iPSC line, IISHDOi005-A, has been generated using a
non-integrative methodology that involves the use of Sendai viruses
containing the reprogramming factors Oct3/4, Sox2, Klf4, and c-Myc
(Takahashi et al., 2007). For this purpose, ﬁbroblasts from a C57BL/6J
mouse with an age of 1 year and a half have been obtained from skin.
IISHDOi005-A iPSC colonies displayed a typical ES-like colony mor-
phology and growth behaviour (Fig. 1A) and they stained positive for
alkaline phosphatase activity (Fig. 1B). The line was conﬁrmed by PCR
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Fig. 1. Molecular and functional characterization of the IISHDOi005-A iPSC line.
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analysis to be mycoplasma-negative (Fig. 1C). Immunoﬂuorescence
analysis revealed expression of transcription factors Oct4, Nanog and
Sox2, and the ES cells surface marker, SSEA1 (Fig. 1D). The endogenous
expression of the pluripotency associated transcription factors Oct4,
Sox2 and Nanog was evaluated by quantitative real time polymerase
chain reaction (qPCR) (Fig. 1E). The iPSC line has been adapted to
feeder-free culture conditions and a karyotype analysis after more than
20 culture passages has been performed (Fig. 1F). This analysis dis-
played a normal (40, XX) karyotype. In addition, we conﬁrmed by DNA
ﬁngerprinting analysis that the line IISHDOi005-A was derived from the
initial mouse ﬁbroblasts (available with the author). The clearance of
the vectors and the exogenous reprogramming factor genes was also
conﬁrmed by RT-PCR after twelve culture passages. Primers used allow
the speciﬁc detection of both human and mouse transgenes because
sequences hybridize with both species (Fig. 1G). Finally, the capacity of
the IISHDOi005-A iPSC line to diﬀerentiate into the three germ layers
(endoderm, mesoderm and ectoderm) was analysed in vitro using an
embryoid body based assay (Fig. 1H).
Materials and methods
Generation of iPSCs
Fibroblasts from an aged C57BL/6J mouse were reprogrammed
using the CytoTune-iPS 2.0 Sendai reprogramming kit following the
instructions of the manufacturer, with minor modiﬁcations (MOI for
KLF4=5). This line was maintained and expanded ﬁrst on feeder
layers (CRL-2429, ATCC), inactivated using mitomycin-C (10 μg/mL for
2 h), using 2i/LIF medium with gelatin as matrix. The composition of
the 2i/LIF medium is: neurobasal medium and DMEM/F-12 Glutamax
(1:1), supplemented with 2% B27, 1% N2, 385 nM β-mercaptoethanol,
0.5% L-Glutamine, 1% penicillin/streptomycin, 1 μM PD0325901, 3 μM
CT99021, 103 U/mL LIF. The line was afterwards adapted to feeder-free
conditions, using ES-Cult™ Maintenance Medium (StemCell
Technologies) and gelatin. Cells were passaged when reaching a
80–90% conﬂuence using Accumax® (Millipore) without rock inhibitor,
approximately once a week and with a 1:5 ratio of split. The incubator
conditions used are 37 °C and 5% CO2.
Phosphatase alkaline analysis
The iPSC line IISHDOi005-A was seeded on a feeder layer plate.
After one week, direct phosphatase alkaline activity was determined
using the phosphatase alkaline blue membrane substrate solution kit
(Sigma, AB0300), (Table 1).
qPCR analysis
Total mRNA was isolated using TRI Reagent® and 1 μg was used to
synthesize cDNA using the Thermo Scientiﬁc RevertAid RT Kit. The
qPCR was carried out with PowerSYBR®Green PCR Master Mix (Applied
Biosystems), and analysed using an Applied Biosystems™ 7500 Fast
Real-Time PCR System. One μl of the reaction was used to quantify by
qPCR the expression of the endogenous pluripotency associated genes
Oct4, Sox2 and Nanog (Table 1). Primers are listed in Table 2. All the
expression values were normalized to the Gapdh gene. Plots are re-
presentative of at least three independent experiments.
Karyotype analysis
Karyotype analyses were carried out using cells with more than
twenty culture passages. Brieﬂy, cells were treated with 10 μg/mL of
Colcemid (Gibco) for 90min at 37 °C, trypsinized, treated with hypo-
tonic solution KCl 0.075M, and ﬁxed with Carnoy's ﬁxative. Cells were
then dropped on a microscope glass slide and dried. Metaphase cells
were G banded using Wright staining. At least 20 metaphases were
karyotyped.
Immunoﬂuorescence analysis
Cells were grown on 0.1% gelatin-coated 35mm culture plates
(81,156, Ibidi), ﬁxed with 4% paraformaldehyde for 30min at RT and
permeabilized using TBS+ (0.1% Triton X-100 in Tris-buﬀered saline,
TBS) for 45min. Then the cells were incubated in TBS++ (3% donkey
serum, 0.3% Triton X-100 in TBS) for two hours at RT. Primary anti-
bodies were applied overnight at 4 °C. Secondary antibodies, for two
hours at RT. Nuclei were stained with DAPI (Sigma, 28718-90-3). The
antibodies were diluted in TBS buﬀer with 3% donkey serum and 0.3%
triton and are listed in Table 2.
In vitro diﬀerentiation assay
The in vitro pluripotency capacity of the line IISHDOi005-A was
tested by spontaneous embryoid body diﬀerentiation. The protocol used
has been described in detail by Galera et al., 2016, with minor mod-
iﬁcations, using ES-Cult™ Maintenance Medium without LIF.
Table 1
Characterization and validation.
Classiﬁcation Test Result Data
Morphology Photography Normal Fig. 1 panel A
Phenotype Qualitative analysis: alkaline phosphatase
activity
Positive Fig. 1 panel B
Qualitative analysis: immunocytochemistry Positive for the pluripotency markers: SSEA1, Nanog, Oct4 and
Sox2
Fig. 1 panel D
Quantitative analysis: gene expression (qPCR) Positive for the pluripotency markers: Oct4, Sox2 and Nanog Fig. 1 panel E
Genotype Karyotype (G-banding) and resolution 40, XX Fig. 1 panel F
Resolution 450–500
Identity Microsatellite PCR (mPCR) OR N/A N/A
STR analysis 8 loci, all matched Available with the
author
Mutation analysis (IF APPLICABLE) Sequencing N/A N/A
Southern Blot OR WGS N/A N/A
Microbiology and virology Mycoplasma Mycoplasma testing by PCR: negative Fig. 1 panel C
Diﬀerentiation potential Embryoid body formation and directed
diﬀerentiation
Positive for: smooth muscle actin (Sma), β-tubulin (Tuj1) and
hepatocyte nuclear factor 4 alpha (Hnf4α)
Fig. 1 panel H
Donor screening (OPTIONAL) HIV 1+2 Hepatitis B, Hepatitis C N/A N/A
Genotype additional info
(OPTIONAL)
Blood group genotyping N/A N/A
HLA tissue typing N/A N/A
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Mycoplasma detection
Mycoplasma detection was performed by PCR analysis using 1mL of
the cell culture supernatant (3 days culture, 90% conﬂuence). After
initial denaturation at 95 °C for 2min, 35 cycles of ampliﬁcation at
95 °C for 30 s, at 55 °C for 30 s, and at 72 °C for 1min, and a ﬁnal ex-
tension at 72 °C of 3min were performed in an Applied Biosystems
Veriti Thermal Cycler (Applied Biosystems). Primers used are speciﬁed
in Table 2. The 300 bp band represents a mycoplasma-positive sample
available in our laboratory (positive control, C+).
DNA ﬁngerprinting analysis
For DNA ﬁngerprinting analysis eight diﬀerent markers (Almeida
et al., 2014) have been ampliﬁed by PCR and analysed by ABI PRISM
3100 Genetic analyzer and Peak Scanner v3.5 (Applied Biosystems),
(Table 2).
Acknowledgments
This work was supported by grants from: 1) the “Fondo de
Investigación Sanitaria, Instituto de Salud Carlos III cofunded by FEDER
funds”: PI13/00556 and PI16/00789 to RG, PI15/00484 and PI18/
00151 to MEG and PI15/00558 to AL. 2) “Comunidad Autónoma de
Madrid” (grant number S2010/BMD-2402 to RG. MdC.O-C receives
grant support from the Ministerio de Educación, Cultura y Deporte
(FPU16/03895). M.GL is supported by a grant from Instituto de
Investigación Sanitaria Hospital 12 de Octubre, i+12. ME.G is sup-
ported by a “Miguel Servet” contract (CP16/00046) from Instituto de
Salud Carlos III and FEDER funds.
References
Almeida, J., Hill, C., Cole, K., 2014. Mouse cell line authentication. Cytotechnology 66
(1), 133–147.
Galera, T., Zurita, F., González-Páramos, C., Moreno-Izquierdo, A., Fraga, M.F.,
Fernández, A.F., Garesse, R., Gallardo, M.E., 2016. Generation of a human iPSC line
from a patient with Leigh syndrome. Stem Cell Res. 16 (1), 63–66.
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., Yamanaka, S.,
2007. Induction of pluripotent stem cells from adult human ﬁbroblasts by deﬁned
factors. Cell 131 (5), 861–872.
Table 2
Reagents details.
Antibodies used for immunocytochemistry/ﬂow-cytometry
Antibody Dilution Company Cat # and RRID
Pluripotency markers Mouse anti-SSEA1 1:100 Abcam Cat# ab16285, RRID: AB_870663
Rabbit anti-Nanog 1:150 Abcam Cat# ab80892, RRID: AB_2150114
Mouse anti-Oct4 1:100 Santa Cruz Biotechnology Cat# sc-5279, RRID: AB_628051
Rabbit anti-Sox2 1:100 Thermo Fisher Scientiﬁc Cat# PA1-16968, RRID: AB_2195781
Diﬀerentiation markers Mouse anti-β tubulin isotype III 1:400 Sigma-Aldrich Cat# T8660, RRID: AB_477590
Mouse anti-Hnf4α 1:250 Thermo-Fisher Cat# K9218, RRID: AB_2633309
Mouse anti-Sma 1:400 Sigma-Aldrich Cat# A2547, RRID: AB_476701
Secondary antibodies Goat anti-mouse IgG (H+ L), Alexa Fluor 488 1:500 Thermo Fisher Scientiﬁc Cat# A-11029, RRID: AB_2534088
Goat anti-rabbit IgG (H+ L), Alexa Fluor 488 1:500 Thermo Fisher Scientiﬁc Cat# A-11034, RRID: AB_2576217
Primers
Target Expected size (bp) Forward/Reverse primer (5′-3′)
Pluripotency markers (qPCR) Endo-Oct4 367 GCCAGACCACCATCTGTC/CCCTGTAGCCTCATACTCT
Endo-Sox2 290 GAGCTAGACTCCGGGCGATG/CTTAAACAAGACCACGAAAACGG
Nanog 219 GTCTGATTCAGAAGGGCTC/CTGGACCGCTCAGTCCTG
House-Keeping Genes (qPCR) Gapdh 122 AGGTCGGTGTGAACGGATTTG/TGTAGACCATGTAGTTGAGGTCA
Virus silencing SeV 181 GGATCACTAGGTGATATCGAGC/ACCAGACAAGAGTTTAAGAGATATGTATC
KOS 528 ATGCACCGCTACGACGTGAGCGC/ACCTTGACAATCCTGATGTGG
Klf4 410 TTCCTGCATGCCAGAGGAGCCC/AATGTATCGAAGGTGCTCAA
c-Myc 532 TAACTGACTAGCAGGCTTGTCG/TCCACATACAGTCCTGGATGATGATG
STR analysis 18–3 149 [6FAM]TCTTTCTCCTTTTGTGTCATGC/GTTTCTTGCTAAATAACTAAGCAAGTGAACAGA
4–2 300 [6FAM]AAGCTTCTCTGGCCATTTGA/GTTCATAAACTTCAAGCAATGACA
6–7 420 [6FAM]AGTCCACCCAGTGCATTCTC/GTTTCTTCATGTGGCTGGTATGCTGTT
9–2 400 [6FAM]GGATTGCCAAGAATTTGAGG/GTTTCTTTCCTGAGTTGTGGACAGGGTTA
15–3 300 [6FAM]TCTGGGCGTGTCTGTCATAA/GTTTCTTTTCTCAGGGAGGAGTGTGCT
6–4 295 [6FAM]TTTGCAACAGCTCAGTTTCC/GTTTCTTAATCGCTGGCAGATCTTAGG
12–1 220 [6FAM]CAAAATTGTCATTGAACACATGTAA/GTTTCTTTCAATGGTCAAGAAATACTGAAGTACAA
5–5 280 [6FAM]CGTTTTACCTGGCTGACACA/GTTTCTTGGTTTAAAACTCAATACCAAACAA
Mycoplasma detection Gpo-3/Mgso 300 GGGAGCAAACAGGATTAGATACCCT/TGCACCATCTGTCACTCTGTTAACCTC
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